MedTrace Logo

Betacyanin for Early Diagnosis and Recovery of Anastomotic Leakage After Rectal Cancer Surgery: A Single-Center, Prospective, Controlled Trial

NCT07726966 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2026-07-27

No results posted yet for this study

Summary

This single-center, prospective, controlled trial compares betacyanin versus conventional methods for early diagnosis and healing assessment of anastomotic leakage after rectal cancer surgery.

Conditions

  • Rectum Cancer
  • Anastomotic Leak

Interventions

DIETARY_SUPPLEMENT

Betacyanin

200 mL oral betacyanin solution administered daily from postoperative day 3 until discharge or confirmation of anastomotic leakage

DIAGNOSTIC_TEST

Pelvic Drainage Fluid Betacyanin Assay

Daily measurement of betacyanin concentration in pelvic drainage fluid for early detection of anastomotic leakage

Sponsors & Collaborators

  • Southwest Hospital, China

    lead OTHER

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-08-20
Primary Completion
2027-05-01
Completion
2027-05-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07726966 on ClinicalTrials.gov